載入中
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
一般交易時段
US$6.69
+US$0.02 · +0.30%
盤中時間採用ET。市場資料可能有所延遲。
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
日內區間
目前US$6.69
52週區間
目前US$6.69
盤中時間採用ET。市場資料可能有所延遲。
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
日內區間
目前US$6.69
52週區間
目前US$6.69
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 5843.5萬 USD | 5349.4萬 USD | 4216.4萬 USD | 3535.8萬 USD | 3445.9萬 USD |
| 銷貨成本 | 3131.3萬 USD | 2764.3萬 USD | 2105.7萬 USD | 1540.3萬 USD | 1662.6萬 USD |
| 毛利 | 2712.2萬 USD | 2585.1萬 USD | 2110.7萬 USD | 1995.5萬 USD | 1783.3萬 USD |
| 研究與開發 | 562.2萬 USD | 532.9萬 USD | 613.9萬 USD | 1181.4萬 USD | 1235.8萬 USD |
| 銷售、一般及管理費用 | 4515.7萬 USD | 2648.8萬 USD | 2610萬 USD | 2717萬 USD | 2388.7萬 USD |
| 營業費用 | 5170萬 USD | 3651.6萬 USD | 3333.6萬 USD | 4013.2萬 USD | 3748.5萬 USD |
| 利息收入 | 9.1萬 USD | 10.3萬 USD | 8.5萬 USD | 1.7萬 USD | 3.4萬 USD |
| 折舊和攤銷 | 450.2萬 USD | 393.1萬 USD | 351.5萬 USD | 340.6萬 USD | 276.4萬 USD |
| 營業利益 | −2457.8萬 USD | −1066.5萬 USD | −1222.9萬 USD | −2017.7萬 USD | −1965.2萬 USD |
| 淨利 | −3428萬 USD | −3140.4萬 USD | −1438.3萬 USD | −1991.4萬 USD | −1960.1萬 USD |
公司資料更新於 2026年10月6日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$12.00
上漲空間 79.37%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI231.54萬0.00%2.3兆 USD0.03%US$383.3+0.71%
Vanguard Extended Market ETFVXF96.06萬0.00%954億 USD0.05%US$237.93+0.32%
Dimensional - US Small Cap ETFDFAS26.34萬0.00%341.54億 USD0.31%US$79.29+0.28%
iShares Micro-Cap ETFIWC20.55萬0.02%13.44億 USD0.60%US$186.45-0.47%
Dimensional - US Targeted Value ETFDFAT14.91萬0.00%303.5億 USD0.33%US$68.16+0.25%
U.S. Micro Cap Portfolio ETFDFMC7.49萬0.00%76.39億 USD0.43%US$58.4347+0.08%
Avantis U.S. Small Cap Equity ETFAVSC6810.75—30.79億 USD0.25%US$70.74+0.14%
Dimensional - US Core Equity 2 ETFDFAC4603.50.00%883.92億 USD0.21%US$45.51+0.53%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASiShares Micro-Cap ETFIWCDimensional - US Targeted Value ETFDFATU.S. Micro Cap Portfolio ETFDFMCAvantis U.S. Small Cap Equity ETFAVSCDimensional - US Core Equity 2 ETFDFACAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
